WINSTON-SALEM, N.C.--(BUSINESS WIRE)--Targacept, Inc. (NASDAQ: TRGT), a clinical-stage biopharmaceutical company developing novel NNR Therapeutics (TM), today announced that J. Donald deBethizy, Ph.D., President and Chief Executive Officer, is scheduled to present at the 30th Annual J.P. Morgan Healthcare Conference at The Westin St. Francis in San Francisco on Thursday, January 12, 2012 at 8:30 a.m. Pacific Time.
